Inventor · disambiguated record
Andrew Mcmichael
Also filed as: MCMICHAEL ANDREW · MCMICHAEL ANDREW J · MCMICHAEL ANDREW JAMES
14 granted patents·14 pending applications·108 citations·filing 1991–2022
92Inventor score
Files withOXXON THERAPEUTICS LTD5ISIS INNOVATION4UNITED BIOMEDICAL INC4HANKE TOMAS2LOS ALAMOS NAT SECURITY LLC2
Top patents by PatentIndex Score
28 records- 0190US7981430B2Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteomeMEDICAL RES COUNCIL·Filed 2007·Granted Jul 19, 2011·11 cites·2 claims
- 0284US7993651B2Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopesMEDICAL RES COUNCIL·Filed 2000·Granted Aug 9, 2011·11 cites·15 claims
- 0382US6663871B1Methods and reagents for vaccination which generate a CD8 T cell immune responseOXXON PHARMACCINES LTD·Filed 1999·Granted Dec 16, 2003·47 cites·20 claims
- 0480US10010606B2Mosaic conserved region HIV immunogenic polypeptidesLOS ALAMOS NAT SECURITY LLC·Filed 2014·Granted Jul 3, 2018·2 cites·20 claims
- 0575US7514087B2Methods and reagents for immunization which generate a CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2004·Granted Apr 7, 2009·4 cites·29 claims
- 0675US7407661B2Methods and reagents that generate a CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2004·Granted Aug 5, 2008·4 cites·25 claims
- 0774US2009324632A1Methods and reagents for vaccination which generate a CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2009·Application pending·0 cites
- 0872US2009191237A1Methods and reagents for vaccination which generate A CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 0967US11235055B2Nucleic acids encoding mosaic conserved region HIV immunogenic polypeptidesLOS ALAMOS NAT SECURITY LLC·Filed 2018·Granted Feb 1, 2022·0 cites·19 claims
- 1067US2025019443A1Antibodies that target hla-e-host peptide complexes and uses thereofUNIV DUKE·Filed 2022·Application pending·0 cites
- 1166US2010119551A1Methods and reagents for vaccination which generate a CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2009·Application pending·0 cites
- 1263US2025051454A1Antibodies that target hla-e-host peptide complexes and uses thereofUNIV DUKE·Filed 2021·Application pending·0 cites
- 1361US2004131594A1Methods and reagents for vaccination which generate a CD8 T cell immune responseFiled 2003·Application pending·0 cites
- 1460US2011159034A1Methods and reagents for vaccination which generate a cd8 t cell immune responseMCMICHAEL ANDREW·Filed 2010·Application pending·0 cites
- 1559US2024076350A1Mhc: peptide complexesUNIV OXFORD INNOVATION LTD·Filed 2021·Application pending·0 cites
- 1658US2024024477A1T cell receptors and uses thereofUNIV OXFORD INNOVATION LTD·Filed 2021·Application pending·0 cites
- 1753US2004213799A1Methods and reagents for vaccination which generate a CD8 T cell immune responseOXXON PHARMACCINES LTD·Filed 2003·Application pending·0 cites
- 1853US2008274475A1Hla-e bindingISIS INNOVATION·Filed 2008·Application pending·0 cites
- 1950US5700635AHIV-1 gag cytotoxic T-lymphocyte epitope and method of useUNITED BIOMEDICAL INC·Filed 1994·Granted Dec 23, 1997·8 cites·7 claims
- 2043US5459238APeptide fragments of HIVUNITED BIOMEDICAL INC·Filed 1992·Granted Oct 17, 1995·4 cites·2 claims
- 2142US8728485B2Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteomeHANKE TOMAS·Filed 2010·Granted May 20, 2014·0 cites·8 claims
- 2241US5395751AAssay for cytotoxic T cellsUNITED BIOMEDICAL INC·Filed 1991·Granted Mar 7, 1995·10 cites·7 claims
- 2340US7410767B1HLA-E bindingISIS INNOVATION·Filed 1998·Granted Aug 12, 2008·5 cites·22 claims
- 2439US2004131598A1Cancer therapyFiled 2001·Application pending·0 cites
- 2539US2015361180A1Hla-e bindingISIS INNOVATION·Filed 2015·Application pending·0 cites
- 2638US2008306244A1Renta: an HIV immunogen and uses thereofHANKE TOMAS·Filed 2006·Application pending·0 cites
- 2737US5683701APeptide fragments of HIVUNITED BIOMEDICAL INC·Filed 1994·Granted Nov 4, 1997·2 cites·3 claims
- 2825US5972351APlasmodium falciparum MHC class I-restricted CTL epitopes derived from pre-erythrocytic stage antigensISIS INNOVATION·Filed 1992·Granted Oct 26, 1999·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Andrew Mcmichael files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →